Medical Care
Global Microecological Drugs Market Research Report 2025
- May 12, 25
- ID: 235395
- Pages: 109
- Figures: 109
- Views: 9
The global market for Microecological Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Microecological drugs refer to pharmaceutical preparations made from normal microorganisms or substances that regulate the normal growth of microorganisms. Simply put, it uses microbial secondary metabolites or directly affects the microbial community through small molecules and other substances to maintain, rebuild or restore a healthy human microecological balance system, and further treat related diseases.
North American market for Microecological Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Microecological Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Microecological Drugs include Finch Therapeutics, Vedanta Biosciences, Azitra, Biomx, DayTwo, Metabolon, Eligo Biosciences, Precigen, Naked Biome, Evelo Biosciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Microecological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microecological Drugs.
The Microecological Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Microecological Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microecological Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Finch Therapeutics
Vedanta Biosciences
Azitra
Biomx
DayTwo
Metabolon
Eligo Biosciences
Precigen
Naked Biome
Evelo Biosciences
Locus Biosciences
Armata Pharmaceuticals
Ritter Pharmaceuticals
Seres Therapeutics
4D Pharma
Assembly Biosciences
AOBiome
Osel Inc
TargEDys
Second Genome
Theriva Biologics, Inc.
MaaT Pharma SA
YSOPIA Bioscience
Pylum Bioscience
Enterome Bioscience
Segment by Type
Living Biopharmaceuticals
Microecological Small Molecule Preparations
Macromolecule Drugs
Phage
Segment by Application
Immune Diseases
Metabolic Disease
Nervous System Disease
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microecological Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microecological Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Microecological drugs refer to pharmaceutical preparations made from normal microorganisms or substances that regulate the normal growth of microorganisms. Simply put, it uses microbial secondary metabolites or directly affects the microbial community through small molecules and other substances to maintain, rebuild or restore a healthy human microecological balance system, and further treat related diseases.
North American market for Microecological Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Microecological Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Microecological Drugs include Finch Therapeutics, Vedanta Biosciences, Azitra, Biomx, DayTwo, Metabolon, Eligo Biosciences, Precigen, Naked Biome, Evelo Biosciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Microecological Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microecological Drugs.
The Microecological Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Microecological Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microecological Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Finch Therapeutics
Vedanta Biosciences
Azitra
Biomx
DayTwo
Metabolon
Eligo Biosciences
Precigen
Naked Biome
Evelo Biosciences
Locus Biosciences
Armata Pharmaceuticals
Ritter Pharmaceuticals
Seres Therapeutics
4D Pharma
Assembly Biosciences
AOBiome
Osel Inc
TargEDys
Second Genome
Theriva Biologics, Inc.
MaaT Pharma SA
YSOPIA Bioscience
Pylum Bioscience
Enterome Bioscience
Segment by Type
Living Biopharmaceuticals
Microecological Small Molecule Preparations
Macromolecule Drugs
Phage
Segment by Application
Immune Diseases
Metabolic Disease
Nervous System Disease
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microecological Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microecological Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Microecological Drugs Market Overview
1.1 Product Definition
1.2 Microecological Drugs by Type
1.2.1 Global Microecological Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Living Biopharmaceuticals
1.2.3 Microecological Small Molecule Preparations
1.2.4 Macromolecule Drugs
1.2.5 Phage
1.3 Microecological Drugs by Application
1.3.1 Global Microecological Drugs Market Value by Application (2024 VS 2031)
1.3.2 Immune Diseases
1.3.3 Metabolic Disease
1.3.4 Nervous System Disease
1.3.5 Other
1.4 Global Microecological Drugs Market Size Estimates and Forecasts
1.4.1 Global Microecological Drugs Revenue 2020-2031
1.4.2 Global Microecological Drugs Sales 2020-2031
1.4.3 Global Microecological Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Microecological Drugs Market Competition by Manufacturers
2.1 Global Microecological Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Microecological Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Microecological Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Microecological Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Microecological Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microecological Drugs, Product Type & Application
2.7 Global Key Manufacturers of Microecological Drugs, Date of Enter into This Industry
2.8 Global Microecological Drugs Market Competitive Situation and Trends
2.8.1 Global Microecological Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Microecological Drugs Players Market Share by Revenue
2.8.3 Global Microecological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Microecological Drugs Market Scenario by Region
3.1 Global Microecological Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Microecological Drugs Sales by Region: 2020-2031
3.2.1 Global Microecological Drugs Sales by Region: 2020-2025
3.2.2 Global Microecological Drugs Sales by Region: 2026-2031
3.3 Global Microecological Drugs Revenue by Region: 2020-2031
3.3.1 Global Microecological Drugs Revenue by Region: 2020-2025
3.3.2 Global Microecological Drugs Revenue by Region: 2026-2031
3.4 North America Microecological Drugs Market Facts & Figures by Country
3.4.1 North America Microecological Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Microecological Drugs Sales by Country (2020-2031)
3.4.3 North America Microecological Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Microecological Drugs Market Facts & Figures by Country
3.5.1 Europe Microecological Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Microecological Drugs Sales by Country (2020-2031)
3.5.3 Europe Microecological Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microecological Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Microecological Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Microecological Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Microecological Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Microecological Drugs Market Facts & Figures by Country
3.7.1 Latin America Microecological Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Microecological Drugs Sales by Country (2020-2031)
3.7.3 Latin America Microecological Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microecological Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Microecological Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Microecological Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Microecological Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Microecological Drugs Sales by Type (2020-2031)
4.1.1 Global Microecological Drugs Sales by Type (2020-2025)
4.1.2 Global Microecological Drugs Sales by Type (2026-2031)
4.1.3 Global Microecological Drugs Sales Market Share by Type (2020-2031)
4.2 Global Microecological Drugs Revenue by Type (2020-2031)
4.2.1 Global Microecological Drugs Revenue by Type (2020-2025)
4.2.2 Global Microecological Drugs Revenue by Type (2026-2031)
4.2.3 Global Microecological Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Microecological Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Microecological Drugs Sales by Application (2020-2031)
5.1.1 Global Microecological Drugs Sales by Application (2020-2025)
5.1.2 Global Microecological Drugs Sales by Application (2026-2031)
5.1.3 Global Microecological Drugs Sales Market Share by Application (2020-2031)
5.2 Global Microecological Drugs Revenue by Application (2020-2031)
5.2.1 Global Microecological Drugs Revenue by Application (2020-2025)
5.2.2 Global Microecological Drugs Revenue by Application (2026-2031)
5.2.3 Global Microecological Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Microecological Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Finch Therapeutics
6.1.1 Finch Therapeutics Company Information
6.1.2 Finch Therapeutics Description and Business Overview
6.1.3 Finch Therapeutics Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Finch Therapeutics Microecological Drugs Product Portfolio
6.1.5 Finch Therapeutics Recent Developments/Updates
6.2 Vedanta Biosciences
6.2.1 Vedanta Biosciences Company Information
6.2.2 Vedanta Biosciences Description and Business Overview
6.2.3 Vedanta Biosciences Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Vedanta Biosciences Microecological Drugs Product Portfolio
6.2.5 Vedanta Biosciences Recent Developments/Updates
6.3 Azitra
6.3.1 Azitra Company Information
6.3.2 Azitra Description and Business Overview
6.3.3 Azitra Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Azitra Microecological Drugs Product Portfolio
6.3.5 Azitra Recent Developments/Updates
6.4 Biomx
6.4.1 Biomx Company Information
6.4.2 Biomx Description and Business Overview
6.4.3 Biomx Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biomx Microecological Drugs Product Portfolio
6.4.5 Biomx Recent Developments/Updates
6.5 DayTwo
6.5.1 DayTwo Company Information
6.5.2 DayTwo Description and Business Overview
6.5.3 DayTwo Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 DayTwo Microecological Drugs Product Portfolio
6.5.5 DayTwo Recent Developments/Updates
6.6 Metabolon
6.6.1 Metabolon Company Information
6.6.2 Metabolon Description and Business Overview
6.6.3 Metabolon Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Metabolon Microecological Drugs Product Portfolio
6.6.5 Metabolon Recent Developments/Updates
6.7 Eligo Biosciences
6.7.1 Eligo Biosciences Company Information
6.7.2 Eligo Biosciences Description and Business Overview
6.7.3 Eligo Biosciences Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Eligo Biosciences Microecological Drugs Product Portfolio
6.7.5 Eligo Biosciences Recent Developments/Updates
6.8 Precigen
6.8.1 Precigen Company Information
6.8.2 Precigen Description and Business Overview
6.8.3 Precigen Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Precigen Microecological Drugs Product Portfolio
6.8.5 Precigen Recent Developments/Updates
6.9 Naked Biome
6.9.1 Naked Biome Company Information
6.9.2 Naked Biome Description and Business Overview
6.9.3 Naked Biome Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Naked Biome Microecological Drugs Product Portfolio
6.9.5 Naked Biome Recent Developments/Updates
6.10 Evelo Biosciences
6.10.1 Evelo Biosciences Company Information
6.10.2 Evelo Biosciences Description and Business Overview
6.10.3 Evelo Biosciences Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Evelo Biosciences Microecological Drugs Product Portfolio
6.10.5 Evelo Biosciences Recent Developments/Updates
6.11 Locus Biosciences
6.11.1 Locus Biosciences Company Information
6.11.2 Locus Biosciences Description and Business Overview
6.11.3 Locus Biosciences Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Locus Biosciences Microecological Drugs Product Portfolio
6.11.5 Locus Biosciences Recent Developments/Updates
6.12 Armata Pharmaceuticals
6.12.1 Armata Pharmaceuticals Company Information
6.12.2 Armata Pharmaceuticals Description and Business Overview
6.12.3 Armata Pharmaceuticals Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Armata Pharmaceuticals Microecological Drugs Product Portfolio
6.12.5 Armata Pharmaceuticals Recent Developments/Updates
6.13 Ritter Pharmaceuticals
6.13.1 Ritter Pharmaceuticals Company Information
6.13.2 Ritter Pharmaceuticals Description and Business Overview
6.13.3 Ritter Pharmaceuticals Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ritter Pharmaceuticals Microecological Drugs Product Portfolio
6.13.5 Ritter Pharmaceuticals Recent Developments/Updates
6.14 Seres Therapeutics
6.14.1 Seres Therapeutics Company Information
6.14.2 Seres Therapeutics Description and Business Overview
6.14.3 Seres Therapeutics Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Seres Therapeutics Microecological Drugs Product Portfolio
6.14.5 Seres Therapeutics Recent Developments/Updates
6.15 4D Pharma
6.15.1 4D Pharma Company Information
6.15.2 4D Pharma Description and Business Overview
6.15.3 4D Pharma Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 4D Pharma Microecological Drugs Product Portfolio
6.15.5 4D Pharma Recent Developments/Updates
6.16 Assembly Biosciences
6.16.1 Assembly Biosciences Company Information
6.16.2 Assembly Biosciences Description and Business Overview
6.16.3 Assembly Biosciences Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Assembly Biosciences Microecological Drugs Product Portfolio
6.16.5 Assembly Biosciences Recent Developments/Updates
6.17 AOBiome
6.17.1 AOBiome Company Information
6.17.2 AOBiome Description and Business Overview
6.17.3 AOBiome Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 AOBiome Microecological Drugs Product Portfolio
6.17.5 AOBiome Recent Developments/Updates
6.18 Osel Inc
6.18.1 Osel Inc Company Information
6.18.2 Osel Inc Description and Business Overview
6.18.3 Osel Inc Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Osel Inc Microecological Drugs Product Portfolio
6.18.5 Osel Inc Recent Developments/Updates
6.19 TargEDys
6.19.1 TargEDys Company Information
6.19.2 TargEDys Description and Business Overview
6.19.3 TargEDys Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 TargEDys Microecological Drugs Product Portfolio
6.19.5 TargEDys Recent Developments/Updates
6.20 Second Genome
6.20.1 Second Genome Company Information
6.20.2 Second Genome Description and Business Overview
6.20.3 Second Genome Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Second Genome Microecological Drugs Product Portfolio
6.20.5 Second Genome Recent Developments/Updates
6.21 Theriva Biologics, Inc.
6.21.1 Theriva Biologics, Inc. Company Information
6.21.2 Theriva Biologics, Inc. Description and Business Overview
6.21.3 Theriva Biologics, Inc. Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Theriva Biologics, Inc. Microecological Drugs Product Portfolio
6.21.5 Theriva Biologics, Inc. Recent Developments/Updates
6.22 MaaT Pharma SA
6.22.1 MaaT Pharma SA Company Information
6.22.2 MaaT Pharma SA Description and Business Overview
6.22.3 MaaT Pharma SA Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.22.4 MaaT Pharma SA Microecological Drugs Product Portfolio
6.22.5 MaaT Pharma SA Recent Developments/Updates
6.23 YSOPIA Bioscience
6.23.1 YSOPIA Bioscience Company Information
6.23.2 YSOPIA Bioscience Description and Business Overview
6.23.3 YSOPIA Bioscience Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.23.4 YSOPIA Bioscience Microecological Drugs Product Portfolio
6.23.5 YSOPIA Bioscience Recent Developments/Updates
6.24 Pylum Bioscience
6.24.1 Pylum Bioscience Company Information
6.24.2 Pylum Bioscience Description and Business Overview
6.24.3 Pylum Bioscience Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Pylum Bioscience Microecological Drugs Product Portfolio
6.24.5 Pylum Bioscience Recent Developments/Updates
6.25 Enterome Bioscience
6.25.1 Enterome Bioscience Company Information
6.25.2 Enterome Bioscience Description and Business Overview
6.25.3 Enterome Bioscience Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Enterome Bioscience Microecological Drugs Product Portfolio
6.25.5 Enterome Bioscience Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microecological Drugs Industry Chain Analysis
7.2 Microecological Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microecological Drugs Production Mode & Process Analysis
7.4 Microecological Drugs Sales and Marketing
7.4.1 Microecological Drugs Sales Channels
7.4.2 Microecological Drugs Distributors
7.5 Microecological Drugs Customer Analysis
8 Microecological Drugs Market Dynamics
8.1 Microecological Drugs Industry Trends
8.2 Microecological Drugs Market Drivers
8.3 Microecological Drugs Market Challenges
8.4 Microecological Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Microecological Drugs by Type
1.2.1 Global Microecological Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Living Biopharmaceuticals
1.2.3 Microecological Small Molecule Preparations
1.2.4 Macromolecule Drugs
1.2.5 Phage
1.3 Microecological Drugs by Application
1.3.1 Global Microecological Drugs Market Value by Application (2024 VS 2031)
1.3.2 Immune Diseases
1.3.3 Metabolic Disease
1.3.4 Nervous System Disease
1.3.5 Other
1.4 Global Microecological Drugs Market Size Estimates and Forecasts
1.4.1 Global Microecological Drugs Revenue 2020-2031
1.4.2 Global Microecological Drugs Sales 2020-2031
1.4.3 Global Microecological Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Microecological Drugs Market Competition by Manufacturers
2.1 Global Microecological Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Microecological Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Microecological Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Microecological Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Microecological Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microecological Drugs, Product Type & Application
2.7 Global Key Manufacturers of Microecological Drugs, Date of Enter into This Industry
2.8 Global Microecological Drugs Market Competitive Situation and Trends
2.8.1 Global Microecological Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Microecological Drugs Players Market Share by Revenue
2.8.3 Global Microecological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Microecological Drugs Market Scenario by Region
3.1 Global Microecological Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Microecological Drugs Sales by Region: 2020-2031
3.2.1 Global Microecological Drugs Sales by Region: 2020-2025
3.2.2 Global Microecological Drugs Sales by Region: 2026-2031
3.3 Global Microecological Drugs Revenue by Region: 2020-2031
3.3.1 Global Microecological Drugs Revenue by Region: 2020-2025
3.3.2 Global Microecological Drugs Revenue by Region: 2026-2031
3.4 North America Microecological Drugs Market Facts & Figures by Country
3.4.1 North America Microecological Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Microecological Drugs Sales by Country (2020-2031)
3.4.3 North America Microecological Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Microecological Drugs Market Facts & Figures by Country
3.5.1 Europe Microecological Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Microecological Drugs Sales by Country (2020-2031)
3.5.3 Europe Microecological Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microecological Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Microecological Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Microecological Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Microecological Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Microecological Drugs Market Facts & Figures by Country
3.7.1 Latin America Microecological Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Microecological Drugs Sales by Country (2020-2031)
3.7.3 Latin America Microecological Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microecological Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Microecological Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Microecological Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Microecological Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Microecological Drugs Sales by Type (2020-2031)
4.1.1 Global Microecological Drugs Sales by Type (2020-2025)
4.1.2 Global Microecological Drugs Sales by Type (2026-2031)
4.1.3 Global Microecological Drugs Sales Market Share by Type (2020-2031)
4.2 Global Microecological Drugs Revenue by Type (2020-2031)
4.2.1 Global Microecological Drugs Revenue by Type (2020-2025)
4.2.2 Global Microecological Drugs Revenue by Type (2026-2031)
4.2.3 Global Microecological Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Microecological Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Microecological Drugs Sales by Application (2020-2031)
5.1.1 Global Microecological Drugs Sales by Application (2020-2025)
5.1.2 Global Microecological Drugs Sales by Application (2026-2031)
5.1.3 Global Microecological Drugs Sales Market Share by Application (2020-2031)
5.2 Global Microecological Drugs Revenue by Application (2020-2031)
5.2.1 Global Microecological Drugs Revenue by Application (2020-2025)
5.2.2 Global Microecological Drugs Revenue by Application (2026-2031)
5.2.3 Global Microecological Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Microecological Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Finch Therapeutics
6.1.1 Finch Therapeutics Company Information
6.1.2 Finch Therapeutics Description and Business Overview
6.1.3 Finch Therapeutics Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Finch Therapeutics Microecological Drugs Product Portfolio
6.1.5 Finch Therapeutics Recent Developments/Updates
6.2 Vedanta Biosciences
6.2.1 Vedanta Biosciences Company Information
6.2.2 Vedanta Biosciences Description and Business Overview
6.2.3 Vedanta Biosciences Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Vedanta Biosciences Microecological Drugs Product Portfolio
6.2.5 Vedanta Biosciences Recent Developments/Updates
6.3 Azitra
6.3.1 Azitra Company Information
6.3.2 Azitra Description and Business Overview
6.3.3 Azitra Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Azitra Microecological Drugs Product Portfolio
6.3.5 Azitra Recent Developments/Updates
6.4 Biomx
6.4.1 Biomx Company Information
6.4.2 Biomx Description and Business Overview
6.4.3 Biomx Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biomx Microecological Drugs Product Portfolio
6.4.5 Biomx Recent Developments/Updates
6.5 DayTwo
6.5.1 DayTwo Company Information
6.5.2 DayTwo Description and Business Overview
6.5.3 DayTwo Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 DayTwo Microecological Drugs Product Portfolio
6.5.5 DayTwo Recent Developments/Updates
6.6 Metabolon
6.6.1 Metabolon Company Information
6.6.2 Metabolon Description and Business Overview
6.6.3 Metabolon Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Metabolon Microecological Drugs Product Portfolio
6.6.5 Metabolon Recent Developments/Updates
6.7 Eligo Biosciences
6.7.1 Eligo Biosciences Company Information
6.7.2 Eligo Biosciences Description and Business Overview
6.7.3 Eligo Biosciences Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Eligo Biosciences Microecological Drugs Product Portfolio
6.7.5 Eligo Biosciences Recent Developments/Updates
6.8 Precigen
6.8.1 Precigen Company Information
6.8.2 Precigen Description and Business Overview
6.8.3 Precigen Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Precigen Microecological Drugs Product Portfolio
6.8.5 Precigen Recent Developments/Updates
6.9 Naked Biome
6.9.1 Naked Biome Company Information
6.9.2 Naked Biome Description and Business Overview
6.9.3 Naked Biome Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Naked Biome Microecological Drugs Product Portfolio
6.9.5 Naked Biome Recent Developments/Updates
6.10 Evelo Biosciences
6.10.1 Evelo Biosciences Company Information
6.10.2 Evelo Biosciences Description and Business Overview
6.10.3 Evelo Biosciences Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Evelo Biosciences Microecological Drugs Product Portfolio
6.10.5 Evelo Biosciences Recent Developments/Updates
6.11 Locus Biosciences
6.11.1 Locus Biosciences Company Information
6.11.2 Locus Biosciences Description and Business Overview
6.11.3 Locus Biosciences Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Locus Biosciences Microecological Drugs Product Portfolio
6.11.5 Locus Biosciences Recent Developments/Updates
6.12 Armata Pharmaceuticals
6.12.1 Armata Pharmaceuticals Company Information
6.12.2 Armata Pharmaceuticals Description and Business Overview
6.12.3 Armata Pharmaceuticals Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Armata Pharmaceuticals Microecological Drugs Product Portfolio
6.12.5 Armata Pharmaceuticals Recent Developments/Updates
6.13 Ritter Pharmaceuticals
6.13.1 Ritter Pharmaceuticals Company Information
6.13.2 Ritter Pharmaceuticals Description and Business Overview
6.13.3 Ritter Pharmaceuticals Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ritter Pharmaceuticals Microecological Drugs Product Portfolio
6.13.5 Ritter Pharmaceuticals Recent Developments/Updates
6.14 Seres Therapeutics
6.14.1 Seres Therapeutics Company Information
6.14.2 Seres Therapeutics Description and Business Overview
6.14.3 Seres Therapeutics Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Seres Therapeutics Microecological Drugs Product Portfolio
6.14.5 Seres Therapeutics Recent Developments/Updates
6.15 4D Pharma
6.15.1 4D Pharma Company Information
6.15.2 4D Pharma Description and Business Overview
6.15.3 4D Pharma Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 4D Pharma Microecological Drugs Product Portfolio
6.15.5 4D Pharma Recent Developments/Updates
6.16 Assembly Biosciences
6.16.1 Assembly Biosciences Company Information
6.16.2 Assembly Biosciences Description and Business Overview
6.16.3 Assembly Biosciences Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Assembly Biosciences Microecological Drugs Product Portfolio
6.16.5 Assembly Biosciences Recent Developments/Updates
6.17 AOBiome
6.17.1 AOBiome Company Information
6.17.2 AOBiome Description and Business Overview
6.17.3 AOBiome Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 AOBiome Microecological Drugs Product Portfolio
6.17.5 AOBiome Recent Developments/Updates
6.18 Osel Inc
6.18.1 Osel Inc Company Information
6.18.2 Osel Inc Description and Business Overview
6.18.3 Osel Inc Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Osel Inc Microecological Drugs Product Portfolio
6.18.5 Osel Inc Recent Developments/Updates
6.19 TargEDys
6.19.1 TargEDys Company Information
6.19.2 TargEDys Description and Business Overview
6.19.3 TargEDys Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 TargEDys Microecological Drugs Product Portfolio
6.19.5 TargEDys Recent Developments/Updates
6.20 Second Genome
6.20.1 Second Genome Company Information
6.20.2 Second Genome Description and Business Overview
6.20.3 Second Genome Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Second Genome Microecological Drugs Product Portfolio
6.20.5 Second Genome Recent Developments/Updates
6.21 Theriva Biologics, Inc.
6.21.1 Theriva Biologics, Inc. Company Information
6.21.2 Theriva Biologics, Inc. Description and Business Overview
6.21.3 Theriva Biologics, Inc. Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Theriva Biologics, Inc. Microecological Drugs Product Portfolio
6.21.5 Theriva Biologics, Inc. Recent Developments/Updates
6.22 MaaT Pharma SA
6.22.1 MaaT Pharma SA Company Information
6.22.2 MaaT Pharma SA Description and Business Overview
6.22.3 MaaT Pharma SA Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.22.4 MaaT Pharma SA Microecological Drugs Product Portfolio
6.22.5 MaaT Pharma SA Recent Developments/Updates
6.23 YSOPIA Bioscience
6.23.1 YSOPIA Bioscience Company Information
6.23.2 YSOPIA Bioscience Description and Business Overview
6.23.3 YSOPIA Bioscience Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.23.4 YSOPIA Bioscience Microecological Drugs Product Portfolio
6.23.5 YSOPIA Bioscience Recent Developments/Updates
6.24 Pylum Bioscience
6.24.1 Pylum Bioscience Company Information
6.24.2 Pylum Bioscience Description and Business Overview
6.24.3 Pylum Bioscience Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Pylum Bioscience Microecological Drugs Product Portfolio
6.24.5 Pylum Bioscience Recent Developments/Updates
6.25 Enterome Bioscience
6.25.1 Enterome Bioscience Company Information
6.25.2 Enterome Bioscience Description and Business Overview
6.25.3 Enterome Bioscience Microecological Drugs Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Enterome Bioscience Microecological Drugs Product Portfolio
6.25.5 Enterome Bioscience Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microecological Drugs Industry Chain Analysis
7.2 Microecological Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microecological Drugs Production Mode & Process Analysis
7.4 Microecological Drugs Sales and Marketing
7.4.1 Microecological Drugs Sales Channels
7.4.2 Microecological Drugs Distributors
7.5 Microecological Drugs Customer Analysis
8 Microecological Drugs Market Dynamics
8.1 Microecological Drugs Industry Trends
8.2 Microecological Drugs Market Drivers
8.3 Microecological Drugs Market Challenges
8.4 Microecological Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Microecological Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Microecological Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Microecological Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Microecological Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Microecological Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Microecological Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Microecological Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Microecological Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Microecological Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Microecological Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Microecological Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Microecological Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Microecological Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microecological Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Microecological Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Microecological Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Microecological Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Microecological Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Microecological Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Microecological Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Microecological Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Microecological Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Microecological Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Microecological Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Microecological Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Microecological Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Microecological Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Microecological Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Microecological Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Microecological Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Microecological Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Microecological Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Microecological Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Microecological Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Microecological Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Microecological Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Microecological Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Microecological Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Microecological Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Microecological Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Microecological Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Microecological Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Microecological Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Microecological Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Microecological Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Microecological Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Microecological Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Microecological Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Microecological Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Microecological Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Microecological Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Microecological Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Microecological Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Microecological Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Microecological Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Microecological Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Microecological Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Microecological Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Microecological Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Microecological Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Microecological Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Microecological Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Microecological Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Microecological Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Microecological Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Microecological Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Microecological Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Microecological Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Finch Therapeutics Company Information
Table 71. Finch Therapeutics Description and Business Overview
Table 72. Finch Therapeutics Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Finch Therapeutics Microecological Drugs Product
Table 74. Finch Therapeutics Recent Developments/Updates
Table 75. Vedanta Biosciences Company Information
Table 76. Vedanta Biosciences Description and Business Overview
Table 77. Vedanta Biosciences Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Vedanta Biosciences Microecological Drugs Product
Table 79. Vedanta Biosciences Recent Developments/Updates
Table 80. Azitra Company Information
Table 81. Azitra Description and Business Overview
Table 82. Azitra Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Azitra Microecological Drugs Product
Table 84. Azitra Recent Developments/Updates
Table 85. Biomx Company Information
Table 86. Biomx Description and Business Overview
Table 87. Biomx Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Biomx Microecological Drugs Product
Table 89. Biomx Recent Developments/Updates
Table 90. DayTwo Company Information
Table 91. DayTwo Description and Business Overview
Table 92. DayTwo Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. DayTwo Microecological Drugs Product
Table 94. DayTwo Recent Developments/Updates
Table 95. Metabolon Company Information
Table 96. Metabolon Description and Business Overview
Table 97. Metabolon Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Metabolon Microecological Drugs Product
Table 99. Metabolon Recent Developments/Updates
Table 100. Eligo Biosciences Company Information
Table 101. Eligo Biosciences Description and Business Overview
Table 102. Eligo Biosciences Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Eligo Biosciences Microecological Drugs Product
Table 104. Eligo Biosciences Recent Developments/Updates
Table 105. Precigen Company Information
Table 106. Precigen Description and Business Overview
Table 107. Precigen Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Precigen Microecological Drugs Product
Table 109. Precigen Recent Developments/Updates
Table 110. Naked Biome Company Information
Table 111. Naked Biome Description and Business Overview
Table 112. Naked Biome Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Naked Biome Microecological Drugs Product
Table 114. Naked Biome Recent Developments/Updates
Table 115. Evelo Biosciences Company Information
Table 116. Evelo Biosciences Description and Business Overview
Table 117. Evelo Biosciences Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Evelo Biosciences Microecological Drugs Product
Table 119. Evelo Biosciences Recent Developments/Updates
Table 120. Locus Biosciences Company Information
Table 121. Locus Biosciences Description and Business Overview
Table 122. Locus Biosciences Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Locus Biosciences Microecological Drugs Product
Table 124. Locus Biosciences Recent Developments/Updates
Table 125. Armata Pharmaceuticals Company Information
Table 126. Armata Pharmaceuticals Description and Business Overview
Table 127. Armata Pharmaceuticals Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Armata Pharmaceuticals Microecological Drugs Product
Table 129. Armata Pharmaceuticals Recent Developments/Updates
Table 130. Ritter Pharmaceuticals Company Information
Table 131. Ritter Pharmaceuticals Description and Business Overview
Table 132. Ritter Pharmaceuticals Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Ritter Pharmaceuticals Microecological Drugs Product
Table 134. Ritter Pharmaceuticals Recent Developments/Updates
Table 135. Seres Therapeutics Company Information
Table 136. Seres Therapeutics Description and Business Overview
Table 137. Seres Therapeutics Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Seres Therapeutics Microecological Drugs Product
Table 139. Seres Therapeutics Recent Developments/Updates
Table 140. 4D Pharma Company Information
Table 141. 4D Pharma Description and Business Overview
Table 142. 4D Pharma Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. 4D Pharma Microecological Drugs Product
Table 144. 4D Pharma Recent Developments/Updates
Table 145. Assembly Biosciences Company Information
Table 146. Assembly Biosciences Description and Business Overview
Table 147. Assembly Biosciences Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Assembly Biosciences Microecological Drugs Product
Table 149. Assembly Biosciences Recent Developments/Updates
Table 150. AOBiome Company Information
Table 151. AOBiome Description and Business Overview
Table 152. AOBiome Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. AOBiome Microecological Drugs Product
Table 154. AOBiome Recent Developments/Updates
Table 155. Osel Inc Company Information
Table 156. Osel Inc Description and Business Overview
Table 157. Osel Inc Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Osel Inc Microecological Drugs Product
Table 159. Osel Inc Recent Developments/Updates
Table 160. TargEDys Company Information
Table 161. TargEDys Description and Business Overview
Table 162. TargEDys Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. TargEDys Microecological Drugs Product
Table 164. TargEDys Recent Developments/Updates
Table 165. Second Genome Company Information
Table 166. Second Genome Description and Business Overview
Table 167. Second Genome Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Second Genome Microecological Drugs Product
Table 169. Second Genome Recent Developments/Updates
Table 170. Theriva Biologics, Inc. Company Information
Table 171. Theriva Biologics, Inc. Description and Business Overview
Table 172. Theriva Biologics, Inc. Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Theriva Biologics, Inc. Microecological Drugs Product
Table 174. Theriva Biologics, Inc. Recent Developments/Updates
Table 175. MaaT Pharma SA Company Information
Table 176. MaaT Pharma SA Description and Business Overview
Table 177. MaaT Pharma SA Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. MaaT Pharma SA Microecological Drugs Product
Table 179. MaaT Pharma SA Recent Developments/Updates
Table 180. YSOPIA Bioscience Company Information
Table 181. YSOPIA Bioscience Description and Business Overview
Table 182. YSOPIA Bioscience Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. YSOPIA Bioscience Microecological Drugs Product
Table 184. YSOPIA Bioscience Recent Developments/Updates
Table 185. Pylum Bioscience Company Information
Table 186. Pylum Bioscience Description and Business Overview
Table 187. Pylum Bioscience Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. Pylum Bioscience Microecological Drugs Product
Table 189. Pylum Bioscience Recent Developments/Updates
Table 190. Enterome Bioscience Company Information
Table 191. Enterome Bioscience Description and Business Overview
Table 192. Enterome Bioscience Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 193. Enterome Bioscience Microecological Drugs Product
Table 194. Enterome Bioscience Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Microecological Drugs Distributors List
Table 198. Microecological Drugs Customers List
Table 199. Microecological Drugs Market Trends
Table 200. Microecological Drugs Market Drivers
Table 201. Microecological Drugs Market Challenges
Table 202. Microecological Drugs Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
List of Figures
Figure 1. Product Picture of Microecological Drugs
Figure 2. Global Microecological Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Microecological Drugs Market Share by Type: 2024 & 2031
Figure 4. Living Biopharmaceuticals Product Picture
Figure 5. Microecological Small Molecule Preparations Product Picture
Figure 6. Macromolecule Drugs Product Picture
Figure 7. Phage Product Picture
Figure 8. Global Microecological Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Microecological Drugs Market Share by Application: 2024 & 2031
Figure 10. Immune Diseases
Figure 11. Metabolic Disease
Figure 12. Nervous System Disease
Figure 13. Other
Figure 14. Global Microecological Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Microecological Drugs Market Size (2020-2031) & (US$ Million)
Figure 16. Global Microecological Drugs Sales (2020-2031) & (K Units)
Figure 17. Global Microecological Drugs Average Price (US$/Unit) & (2020-2031)
Figure 18. Microecological Drugs Report Years Considered
Figure 19. Microecological Drugs Sales Share by Manufacturers in 2024
Figure 20. Global Microecological Drugs Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Microecological Drugs Players: Market Share by Revenue in Microecological Drugs in 2024
Figure 22. Microecological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Microecological Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Microecological Drugs Sales Market Share by Country (2020-2031)
Figure 25. North America Microecological Drugs Revenue Market Share by Country (2020-2031)
Figure 26. United States Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Microecological Drugs Sales Market Share by Country (2020-2031)
Figure 29. Europe Microecological Drugs Revenue Market Share by Country (2020-2031)
Figure 30. Germany Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Microecological Drugs Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Microecological Drugs Revenue Market Share by Region (2020-2031)
Figure 37. China Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Microecological Drugs Sales Market Share by Country (2020-2031)
Figure 45. Latin America Microecological Drugs Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Microecological Drugs Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Microecological Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Microecological Drugs by Type (2020-2031)
Figure 55. Global Revenue Market Share of Microecological Drugs by Type (2020-2031)
Figure 56. Global Microecological Drugs Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Microecological Drugs by Application (2020-2031)
Figure 58. Global Revenue Market Share of Microecological Drugs by Application (2020-2031)
Figure 59. Global Microecological Drugs Price (US$/Unit) by Application (2020-2031)
Figure 60. Microecological Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Microecological Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Microecological Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Microecological Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Microecological Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Microecological Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Microecological Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Microecological Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Microecological Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Microecological Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Microecological Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Microecological Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Microecological Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Microecological Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microecological Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Microecological Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Microecological Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Microecological Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Microecological Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Microecological Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Microecological Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Microecological Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Microecological Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Microecological Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Microecological Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Microecological Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Microecological Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Microecological Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Microecological Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Microecological Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Microecological Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Microecological Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Microecological Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Microecological Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Microecological Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Microecological Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Microecological Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Microecological Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Microecological Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Microecological Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Microecological Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Microecological Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Microecological Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Microecological Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Microecological Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Microecological Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Microecological Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Microecological Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Microecological Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Microecological Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Microecological Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Microecological Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Microecological Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Microecological Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Microecological Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Microecological Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Microecological Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Microecological Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Microecological Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Microecological Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Microecological Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Microecological Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Microecological Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Microecological Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Microecological Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Microecological Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Microecological Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Microecological Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Microecological Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Finch Therapeutics Company Information
Table 71. Finch Therapeutics Description and Business Overview
Table 72. Finch Therapeutics Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Finch Therapeutics Microecological Drugs Product
Table 74. Finch Therapeutics Recent Developments/Updates
Table 75. Vedanta Biosciences Company Information
Table 76. Vedanta Biosciences Description and Business Overview
Table 77. Vedanta Biosciences Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Vedanta Biosciences Microecological Drugs Product
Table 79. Vedanta Biosciences Recent Developments/Updates
Table 80. Azitra Company Information
Table 81. Azitra Description and Business Overview
Table 82. Azitra Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Azitra Microecological Drugs Product
Table 84. Azitra Recent Developments/Updates
Table 85. Biomx Company Information
Table 86. Biomx Description and Business Overview
Table 87. Biomx Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Biomx Microecological Drugs Product
Table 89. Biomx Recent Developments/Updates
Table 90. DayTwo Company Information
Table 91. DayTwo Description and Business Overview
Table 92. DayTwo Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. DayTwo Microecological Drugs Product
Table 94. DayTwo Recent Developments/Updates
Table 95. Metabolon Company Information
Table 96. Metabolon Description and Business Overview
Table 97. Metabolon Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Metabolon Microecological Drugs Product
Table 99. Metabolon Recent Developments/Updates
Table 100. Eligo Biosciences Company Information
Table 101. Eligo Biosciences Description and Business Overview
Table 102. Eligo Biosciences Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Eligo Biosciences Microecological Drugs Product
Table 104. Eligo Biosciences Recent Developments/Updates
Table 105. Precigen Company Information
Table 106. Precigen Description and Business Overview
Table 107. Precigen Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Precigen Microecological Drugs Product
Table 109. Precigen Recent Developments/Updates
Table 110. Naked Biome Company Information
Table 111. Naked Biome Description and Business Overview
Table 112. Naked Biome Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Naked Biome Microecological Drugs Product
Table 114. Naked Biome Recent Developments/Updates
Table 115. Evelo Biosciences Company Information
Table 116. Evelo Biosciences Description and Business Overview
Table 117. Evelo Biosciences Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Evelo Biosciences Microecological Drugs Product
Table 119. Evelo Biosciences Recent Developments/Updates
Table 120. Locus Biosciences Company Information
Table 121. Locus Biosciences Description and Business Overview
Table 122. Locus Biosciences Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Locus Biosciences Microecological Drugs Product
Table 124. Locus Biosciences Recent Developments/Updates
Table 125. Armata Pharmaceuticals Company Information
Table 126. Armata Pharmaceuticals Description and Business Overview
Table 127. Armata Pharmaceuticals Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Armata Pharmaceuticals Microecological Drugs Product
Table 129. Armata Pharmaceuticals Recent Developments/Updates
Table 130. Ritter Pharmaceuticals Company Information
Table 131. Ritter Pharmaceuticals Description and Business Overview
Table 132. Ritter Pharmaceuticals Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Ritter Pharmaceuticals Microecological Drugs Product
Table 134. Ritter Pharmaceuticals Recent Developments/Updates
Table 135. Seres Therapeutics Company Information
Table 136. Seres Therapeutics Description and Business Overview
Table 137. Seres Therapeutics Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Seres Therapeutics Microecological Drugs Product
Table 139. Seres Therapeutics Recent Developments/Updates
Table 140. 4D Pharma Company Information
Table 141. 4D Pharma Description and Business Overview
Table 142. 4D Pharma Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. 4D Pharma Microecological Drugs Product
Table 144. 4D Pharma Recent Developments/Updates
Table 145. Assembly Biosciences Company Information
Table 146. Assembly Biosciences Description and Business Overview
Table 147. Assembly Biosciences Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Assembly Biosciences Microecological Drugs Product
Table 149. Assembly Biosciences Recent Developments/Updates
Table 150. AOBiome Company Information
Table 151. AOBiome Description and Business Overview
Table 152. AOBiome Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. AOBiome Microecological Drugs Product
Table 154. AOBiome Recent Developments/Updates
Table 155. Osel Inc Company Information
Table 156. Osel Inc Description and Business Overview
Table 157. Osel Inc Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Osel Inc Microecological Drugs Product
Table 159. Osel Inc Recent Developments/Updates
Table 160. TargEDys Company Information
Table 161. TargEDys Description and Business Overview
Table 162. TargEDys Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. TargEDys Microecological Drugs Product
Table 164. TargEDys Recent Developments/Updates
Table 165. Second Genome Company Information
Table 166. Second Genome Description and Business Overview
Table 167. Second Genome Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Second Genome Microecological Drugs Product
Table 169. Second Genome Recent Developments/Updates
Table 170. Theriva Biologics, Inc. Company Information
Table 171. Theriva Biologics, Inc. Description and Business Overview
Table 172. Theriva Biologics, Inc. Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Theriva Biologics, Inc. Microecological Drugs Product
Table 174. Theriva Biologics, Inc. Recent Developments/Updates
Table 175. MaaT Pharma SA Company Information
Table 176. MaaT Pharma SA Description and Business Overview
Table 177. MaaT Pharma SA Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. MaaT Pharma SA Microecological Drugs Product
Table 179. MaaT Pharma SA Recent Developments/Updates
Table 180. YSOPIA Bioscience Company Information
Table 181. YSOPIA Bioscience Description and Business Overview
Table 182. YSOPIA Bioscience Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. YSOPIA Bioscience Microecological Drugs Product
Table 184. YSOPIA Bioscience Recent Developments/Updates
Table 185. Pylum Bioscience Company Information
Table 186. Pylum Bioscience Description and Business Overview
Table 187. Pylum Bioscience Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. Pylum Bioscience Microecological Drugs Product
Table 189. Pylum Bioscience Recent Developments/Updates
Table 190. Enterome Bioscience Company Information
Table 191. Enterome Bioscience Description and Business Overview
Table 192. Enterome Bioscience Microecological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 193. Enterome Bioscience Microecological Drugs Product
Table 194. Enterome Bioscience Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Microecological Drugs Distributors List
Table 198. Microecological Drugs Customers List
Table 199. Microecological Drugs Market Trends
Table 200. Microecological Drugs Market Drivers
Table 201. Microecological Drugs Market Challenges
Table 202. Microecological Drugs Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
List of Figures
Figure 1. Product Picture of Microecological Drugs
Figure 2. Global Microecological Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Microecological Drugs Market Share by Type: 2024 & 2031
Figure 4. Living Biopharmaceuticals Product Picture
Figure 5. Microecological Small Molecule Preparations Product Picture
Figure 6. Macromolecule Drugs Product Picture
Figure 7. Phage Product Picture
Figure 8. Global Microecological Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Microecological Drugs Market Share by Application: 2024 & 2031
Figure 10. Immune Diseases
Figure 11. Metabolic Disease
Figure 12. Nervous System Disease
Figure 13. Other
Figure 14. Global Microecological Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Microecological Drugs Market Size (2020-2031) & (US$ Million)
Figure 16. Global Microecological Drugs Sales (2020-2031) & (K Units)
Figure 17. Global Microecological Drugs Average Price (US$/Unit) & (2020-2031)
Figure 18. Microecological Drugs Report Years Considered
Figure 19. Microecological Drugs Sales Share by Manufacturers in 2024
Figure 20. Global Microecological Drugs Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Microecological Drugs Players: Market Share by Revenue in Microecological Drugs in 2024
Figure 22. Microecological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Microecological Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Microecological Drugs Sales Market Share by Country (2020-2031)
Figure 25. North America Microecological Drugs Revenue Market Share by Country (2020-2031)
Figure 26. United States Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Microecological Drugs Sales Market Share by Country (2020-2031)
Figure 29. Europe Microecological Drugs Revenue Market Share by Country (2020-2031)
Figure 30. Germany Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Microecological Drugs Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Microecological Drugs Revenue Market Share by Region (2020-2031)
Figure 37. China Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Microecological Drugs Sales Market Share by Country (2020-2031)
Figure 45. Latin America Microecological Drugs Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Microecological Drugs Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Microecological Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Microecological Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Microecological Drugs by Type (2020-2031)
Figure 55. Global Revenue Market Share of Microecological Drugs by Type (2020-2031)
Figure 56. Global Microecological Drugs Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Microecological Drugs by Application (2020-2031)
Figure 58. Global Revenue Market Share of Microecological Drugs by Application (2020-2031)
Figure 59. Global Microecological Drugs Price (US$/Unit) by Application (2020-2031)
Figure 60. Microecological Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232